Radiation Therapy for Osteosarcoma

 

Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells. It can be given internally or externally:

  • External beam radiation therapy (EBRT) - Radiation from a high-energy x-ray machine (linear accelerator) outside the body is focused on the cancer cells. EBRT can harm both the cancer cells and nearby healthy tissue. Most people are treated with EBRT for a few minutes 5 days a week for several weeks as an outpatient. EBRT is the most common kind of radiation therapy for osteosarcoma.
  • Bone-seeking isotopes - A bone-seeking radioactive chemical, such as samarium-153, is injected into a vein. The chemical attaches to active areas of bone formation, including osteosarcoma. This treatment is useful for treating advanced disease and reducing pain.
  • Internal radiation therapy (brachytherapy or interstitial radiation therapy) - Small pellets (or “seeds”) that contain radioactive materials are placed in your body in or near the tumor. The radioactive pellets release their radiation slowly over time. Brachytherapy lets the doctor use a higher dose of radiation than EBRT.

It is difficult to kill osteosarcoma cells with radiation, so radiation therapy is not usually used to treat the disease. However, it can be useful for patients with tumors that cannot be completely removed by surgery, such as tumors in the pelvic or facial bones. In these cases, the surgeon removes as much of the tumor as possible and then radiation is used to kill the cancer that is left. Radiation therapy is also useful for treating certain symptoms, such as pain and swelling, if the cancer has come back (recurred) after treatment. 

This content has been reviewed and approved by Myo Thant, MD. 

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Osteosarcoma News
UK watchdog changes mind to back bone cancer drug

September 7, 2011 — LONDON(Reuters) - Britain's health costs watchdog NICE has decided to back Japanese drugmaker Takeda's bone cancer drug Mepact after re-assessing the impact of a discount on the medicine for patients in the state-funded National Health Service (NHS).

Osteoporosis drug regrows jaw bone: study

October 18, 2010 — BOSTON (Reuters) - The osteoporosis drug Forteo can regrow bone in jaws damaged by severe bone-destroying conditions called osteonecrosis and periodontitis, doctors reported on Saturday.

Childhood radiation therapy ups breast cancer risk

July 20, 2009 — NEW YORK (Reuters Health) - The results of a study confirm that girls who undergo radiation for cancer in childhood have an increased long-term risk of developing breast cancer, regardless of their age at the time of treatment.

Select news items provided by Reuters Health